📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature. (2010)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ijcard.2008.12.091

PubMed Identifier: 19176251

Publication URI: http://europepmc.org/abstract/MED/19176251

Type: Journal Article/Review

Volume: 142

Parent Publication: International journal of cardiology

Issue: 2

ISSN: 0167-5273